Hypertension is most important and life-threatening disease affecting cardiovascular system. Drugs of choice, among others comprise of substances inhibiting RAAS, i.e.
ACE inhibitors and sartans. The article summarizes current knowledge concerning the comparison of these groups of drugs in terms of fundamental pharmacological properties, clinical efficacy and safety.